Total glucosides of paeony induces regulatory CD4 +CD25 + T cells by increasing Foxp3 demethylation in lupus CD4 + T cells

Clinical Immunology

Volumn 143, Issue 2, 2012, Pages 180-187

  Zhao, Ming ^a   Liang, Gong ping ^a   Tang, Mei ni ^a   Luo, Shuang yan ^a   Zhang, Jing ^a   Cheng, Wen jing ^a   Chan, Tak Mao ^b   Lu, Qian jin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CD4 + T cells; DNA methylation; Foxp3; Systemic lupus erythematosus; Total glucosides of paeony

Indexed keywords

BETA ACTIN; DNA; GAMMA INTERFERON; INTERLEUKIN 2; PAEONIA RADIX; TOTAL GLUCOSIDES OF PAEONY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSIDES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; PAEONIA; RNA, MESSENGER; YOUNG ADULT;

EID: 84862830294     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.02.002     Document Type: Article

References (32)

1. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006, 212:8-27.
2. Miyara M., Gorochov G., Ehrenstein M., Musset L., Sakaguchi S., Amoura Z. Human FoxP3(+) regulatory T cells in systemic autoimmune diseases. Autoimmun. Rev. 2011, 10:744-755.
3. Bonelli M., von Dalwigk K., Savitskaya A., Smolen J.S., Scheinecker C. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Ann. Rheum. Dis. 2008, 67:664-671.
4. Lee J.H., Wang L.C., Lin Y.T., Yang Y.H., Lin D.T., Chiang B.L. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006, 117:280-286.
5. Mellor-Pita S., Citores M.J., Castejon R., Tutor-Ureta P., Yebra-Bango M., Andreu J.L., et al. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2006, 65:553-554.
6. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 2005, 175:8392-8400.
7. Yang J., Chu Y., Yang X., Gao D., Zhu L., Yang X., et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 2009, 60:1472-1483.
8. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
9. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
10. Janson P.C., Winerdal M.E., Marits P., Thorn M., Ohlsson R., Winqvist O. FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS One 2008, 3:e1612.
11. Lal G., Zhang N., van der Touw W., Ding Y., Ju W., Bottinger E.P., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009, 182:259-273.
12. Zheng Q., Xu Y., Liu Y., Zhang B., Li X., Guo F., et al. Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice. J. Mol. Med. (Berl) 2009, 87:1191-1205.
13. Cao W., Zhang W., Liu J., Wang Y., Peng X., Lu D., et al. Paeoniflorin improves survival in LPS-challenged mice through the suppression of TNF-alpha and IL-1beta release and augmentation of IL-10 production. Int. Immunopharmacol. 2011, 11:172-178.
14. Huang H., Chang E.J., Lee Y., Kim J.S., Kang S.S., Kim H.H. A genome-wide microarray analysis reveals anti-inflammatory target genes of paeonol in macrophages. Inflamm. Res. 2008, 57:189-198.
15. Zhang L.L., Wei W., Wang N.P., Wang Q.T., Chen J.Y., Chen Y., et al. Paeoniflorin suppresses inflammatory mediator production and regulates G protein-coupled signaling in fibroblast-like synoviocytes of collagen induced arthritic rats. Inflamm. Res. 2008, 57:388-395.
16. Liu D.F., Wei W., Song L.H. Protective effect of paeoniflorin on immunological liver injury induced by bacillus Calmette-Guerin plus lipopolysaccharide: modulation of tumour necrosis factor-alpha and interleukin-6 MRNA. Clin. Exp. Pharmacol. Physiol. 2006, 33:332-339.
17. Chang Y., Wei W., Zhang L., Xu H.M. Effects and mechanisms of total glucosides of paeony on synoviocytes activities in rat collagen-induced arthritis. J. Ethnopharmacol. 2009, 121:43-48.
18. Ding Z.X., Yang S.F., Wu Q.F., Lu Y., Chen Y.Y., Nie X.L., et al. Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mice. Nan Fang Yi Ke Da Xue Xue Bao. 2011, 31:656-660.
19. Zhang H.F., Xiao W.G., Hou P. Clinical study of total glucosides of paeony in patients with systemic lupus erythematosus. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011, 31:476-479.
20. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
21. Wang Z., Hong J., Sun W., Xu G., Li N., Chen X., et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J. Clin. Invest. 2006, 116:2434-2441.
22. Zheng S.G., Wang J., Wang P., Gray J.D., Horwitz D.A. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 2007, 178:2018-2027.
23. Heinlen L.D., McClain M.T., Merrill J., Akbarali Y.W., Edgerton C.C., Harley J.B., et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum. 2007, 56:2344-2351.
24. La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus 2008, 17:421-425.
25. Crispin J.C., Kyttaris V.C., Terhorst C., Tsokos G.C. T cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 2010, 6:317-325.
26. Hong J., Li N., Zhang X., Zheng B., Zhang J.Z. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6449-6454.
27. Fu S., Zhang N., Yopp A.C., Chen D., Mao M., Chen D., et al. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. Am. J. Transplant. 2004, 4:1614-1627.
28. Nishibori T., Tanabe Y., Su L., David M. Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 2004, 199:25-34.
29. Lieberman L.A., Tsokos G.C. The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J. Biomed. Biotechnol. 2010, 2010:740619.
30. Zorn E., Nelson E.A., Mohseni M., Porcheray F., Kim H., Litsa D., et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006, 108:1571-1579.
31. Hedrich C.M., Rauen T., Tsokos G.C. cAMP-responsive element modulator (CREM)alpha protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus. J. Biol. Chem. 2011, 286:43429-43436.
32. Jones B., Chen J. Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J. 2006, 25:2443-2452.